Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 7
2004 11
2005 9
2006 13
2007 14
2008 8
2009 13
2010 13
2011 14
2012 8
2013 6
2014 15
2015 14
2016 22
2017 28
2018 24
2019 33
2020 29
2021 31
2022 28
2023 36
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

348 results

Results by year

Filters applied: . Clear all
Page 1
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
Scheid C, Eikema DJ, Van Gelder M, Salmenniemi U, Maertens J MD, Passweg JR, Blaise D, Byrne JL, Kroeger N, Sockel K, Chevallier P, Bourhis JH, Cornelissen JJ, Sengeloev H, Finke J, Snowden JA, Gedde-Dahl T, Cornillon J, Schanz U, Patel A, Koster L, de Wreede LC, Hayden PJ, Raj K, Drozd-Sokolowska J, Gurnari C, Onida F, McLornan DP, Robin M, Yakoub-Agha I. Scheid C, et al. Among authors: bourhis jh. Blood. 2024 May 10:blood.2023022273. doi: 10.1182/blood.2023022273. Online ahead of print. Blood. 2024. PMID: 38728380
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Guigay J, Ortholan C, Vansteene D, Cupissol D, Even C, Kaminsky MC, Sire C, Blot E, Debourdeau P, Bozec L, Saada-Bouzid E, Fayette J, Dalloz P, Pointreau Y, Caer HL, Falandry C, Digue L, Braccini A, Lopez S, Guillet P, Michel C, Cheurfa N, Schwob D, Bourhis J, Mertens C, Aupérin A; ELAN Group including Gustave Roussy, Unicancer GERICO and H&N groups and the GORTEC. Guigay J, et al. Among authors: bourhis j. Lancet Healthy Longev. 2024 Mar;5(3):e182-e193. doi: 10.1016/S2666-7568(23)00284-2. Lancet Healthy Longev. 2024. PMID: 38432247 Free article. Clinical Trial.
Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances.
Böhlen TT, Germond JF, Desorgher L, Veres I, Bratel A, Landström E, Engwall E, Herrera FG, Ozsahin EM, Bourhis J, Bochud F, Moeckli R. Böhlen TT, et al. Among authors: bourhis j. Radiother Oncol. 2024 May;194:110177. doi: 10.1016/j.radonc.2024.110177. Epub 2024 Feb 18. Radiother Oncol. 2024. PMID: 38378075 Free article.
Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.
Kinj R, Gaide O, Jeanneret-Sozzi W, Dafni U, Viguet-Carrin S, Sagittario E, Kypriotou M, Chenal J, Duclos F, Hebeisen M, Falco T, Geyer R, Gonçalves Jorge P, Moeckli R, Bourhis J. Kinj R, et al. Among authors: bourhis j. Clin Transl Radiat Oncol. 2024 Feb 8;45:100743. doi: 10.1016/j.ctro.2024.100743. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2024. PMID: 38362466 Free PMC article.
Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study.
Moser O, Ngoya M, Galimard JE, Dalissier A, Dalle JH, Kalwak K, Wössmann W, Burkhardt B, Bierings M, Gonzalez-Vicent M, López Corral L, Mellgren K, Attarbaschi A, Bourhis JH, Carlson K, Corbacioglu S, Drabko K, Sundin M, Toporski J, Cario G, Kontny U. Moser O, et al. Among authors: bourhis jh. Bone Marrow Transplant. 2024 May;59(5):604-614. doi: 10.1038/s41409-024-02226-1. Epub 2024 Feb 8. Bone Marrow Transplant. 2024. PMID: 38331982 Free PMC article.
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
Rovó A, Gras L, Piepenbroek B, Kröger N, Reinhardt HC, Radujkovic A, Blaise D, Kobbe G, Niityvuopio R, Platzbecker U, Sockel K, Hunault-Berger M, Cornelissen JJ, Forcade E, Bourhis JH, Chalandon Y, Kinsella F, Nguyen-Quoc S, Maertens J, Elmaagacli A, Mordini N, Hayden P, Raj K, Drozd-Sokolowska J, de Wreede LC, McLornan DP, Robin M, Yakoub-Agha I, Onida F. Rovó A, et al. Among authors: bourhis jh. Am J Hematol. 2024 Feb;99(2):203-215. doi: 10.1002/ajh.27150. Epub 2023 Nov 27. Am J Hematol. 2024. PMID: 38009469 Free article.
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation.
Spyridonidis A, Labopin M, Gedde-Dahl T, Ganser A, Stelljes M, Craddock C, Wagner-Drouet EM, Versluis J, Schroeder T, Blau IW, Wulf GG, Dreger P, Olesen G, Sengeloev H, Kröger N, Potter V, Forcade E, Passweg J, de Latour RP, Maertens J, Wilson KMO, Bourhis JH, Finke J, Brissot E, Bazarbachi A, Giebel S, Savani BP, Nagler A, Ciceri F, Mohty M. Spyridonidis A, et al. Among authors: bourhis jh. Bone Marrow Transplant. 2024 Feb;59(2):217-223. doi: 10.1038/s41409-023-02139-5. Epub 2023 Nov 17. Bone Marrow Transplant. 2024. PMID: 37978322 Free PMC article.
348 results